NXN Price sensitive 23 Mar 2026, 8:26 AM

FDA feedback derisks US approval pathway for StrepSure

Nexsen Ltd

No summary is available for this announcement — open the PDF to read it in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in